Jill Hollway, Ph.D. M.A.

Research Scientist

Research Unit

(614) 688-3848
jill.hollway@osumc.edu

Biography:

Discipline(s):

Psychiatry

Education:

  • The Ohio State University: PhD, Intellectual and Developmental Disabilities Psychology, 2012
The Ohio State University: M.A., Special Education; Applied Behavior Analysis, 2004
 Ohio Wesleyan University: B.A., Psychology, 1998

Research:

  • Intervention research for sleep disturbance in children with ASD and ADHD
  • Intervention research for children with ASD and co-morbid behavioral problems
  • Intervention research  for children with ADHD

Service:

  • 2013-Present Member of the Autism Speaks Network / Autism Intervention Research Network on Physical Health (AS ATN/AIR-P) Scientific Review Committee (SRC). Reviews research proposals, from network investigators, external proposals both for network research and for use of ATN registry data, manuscripts and abstracts.
  • Adhoc Editorial Reviews 2012-Present
  • Autism: International Journal of Research and Practice.
  • Journal of Autism and Developmental Disorders
  • Journal of Child and Adolescent Psychopharmacology
  • Journal of Mental Health Research in Intellectual Disability
  • Journal of Abnormal Psychology

Selected Publications:

Research Units on Pediatric Psychopharmacology Autism Network (McCracken, J.T., McGough,

J., Shah, B., Cronin, P., Hong, D., Aman, M.G., Arnold, L.E.,  Lindsay, R.L., Nash, P., Hollway, J., McDougle, C.J., Posey, D., Swiezy, N., Kohn A.,   Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N. M., Grados, M., Vitiello, B., Ritz, L., Davies, M., Robinson, J., McMahon, D.) (2002). A double-blind, placebo-controlled trial of risperidone in children with autistic disorder. The New England Journal of Medicine, 347, 314-321.

Arnold, L.E., Vitiello, B., McDougle, C.J., Scahill, L., Shah, B., Gonzalez, N.M.,

Chuang, S., Davies, M., Hollway, J.A., Aman, M.G., Cronin, P., Koenig K., Kohn, A.E., McMahon, D.J., Tierney, E. (2003). Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials. J. Am. Acad. Child and Adolesc. Psychiatry 42, 1443-1450.

McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E.,Davies, M., Arnold, L.E., Posey, D.J., Martin, A., Ghuman, J.K., Shah, B., Chuang, S.Z., Swiezy, N.B., Gonzalez, N.M., Hollway, J., Koenig, K., McGough, J., Ritz, L., Vitiello, B. (2005).  Risperidone for the core symptom domains of autism:  Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry, 162, 1142-1148.

Research Units on Pediatric Psychopharmacology Autism Network (Aman, M.G., Arnold, L.E., Lindsay, R., Nash, P., Hollway, J., McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., McDougle, C.J., Posey, D., Swiezy, N., Kohn, A., Scahill L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N.M.,  Grados, M.). (2005). Risperidone treatment of autistic disorder: Longer term benefits and blinded discontinuation after six months. American Journal of Psychiatry, 162, 1361-1369.

Arnold LE, Bozzolo H, Hollway J, Cook, A, DiSilvestro R, Bozzolo D, Crowl L, Ramadan Y,

Williams C., (2005). Serum zinc correlates with parent/teacher-rated inattention in children with attention-deficit/hyperactivity disorder. J. Child & Adolescent Psychopharmacology 15, 628-636.

Lecavalier, L., Aman, M.G., Scahill, L., McDougle, C.J., Vitiello, B., Tierney, E., McCracken, J.T., Arnold, L.E., Ghuman, J.K., Posey, D.J., Koenig, K., Cronin, P., Lofton, R.L., Martin, A., Hollway, J., Kau, A.S., Lee, L. (2006). The validity of the Autism Diagnostic Interview−Revised. American Journal on Mental Retardation 111, 199-215.

Williams, S.K., Scahill L., Vitiello, B., Aman, M.G., Arnold, L.E., McDougle, C.J.,

McCracken, J.T., Tierney, E., Ritz, L., Posey, D.J., Swiezy N.B., Hollway, J., Cronin,

P., Ghuman, J., Wheeler, C., Cicchetti, D., Sparrow, S. (2006). Risperidone and

Adaptive Behavior in Children with Autism. Journal of the American Academy of Child   and Adolescent Psychiatry, 45, 431-439.

Research Units on Pediatric Psychopharmacology [RUPP] Autism Network (Including Hollway, J.A., at O.S.U. site). (2007). Parent training for children with Pervasive Developmental Disorders: A multi-site feasibility trial. Behavior Interventions, 22, 179-199.

Clark, D.L., Arnold, L.e., Crowl, L., Bozzolo, H., Peruggia, Ramadan, Y., Bornstein, R.,

Hollway, J.A., Thompson. S., Malone, K., Hall, K.L., Shelton, S.B., Bozzolo, D.R., Cook, A. (2008) Vestibular Stimulation for ADHD. Journal of Attention Disorders 11,  599-611.

Aman, M.G., Hollway, J.A., McDougle, C.J., Scahill, L., Tierney, E., McCracken, J. Arnold,

L.E. Vitiello, B., Ritz, L., Gavaletz, A., Cronin, P., Swieay, N.B., Wheeler, C., Koenig,

K., Ghuman, J., Posey, D.J. (2008) Cognitive effects of risperidone in children with autism and irritable behavior Journal of Child and Adolescent Psychopharmacology.

18, 227-236.

Aman, M.G., Farmer, C., Hollway, J.A., Arnold, L.E. (2008) Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Clinics of North America 17, 713-738.

Aman, M.G., Hollway, J.A., Leone, S., Masty, J., Lindsay, R.L., Nash, P. (2009) Effects of risperidone on Cognitive-motor performance in chronically medicated children. Research in Developmental Disabilities 30, 386-396.

Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Eric Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, Kohn AE, Koenig K, Hollway JA, Korzekwa P, Gavaletz A,  Mulick JA, Hall KL, Dziura J, Ritz L, Trollinger S, Yu S, Vitiello B, Wagner A, and the Research Units on Pediatric Psychopharmacology Autism Network. (2009). Medication and Parent Training in Children with Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 48, 1143-1154.

Aman, M.G., Arnold, L.E., Lecavalier, L., Hollway, J.A., Mulick, J.A., McDougle, C.J., Swiezy, N.B., Stigler, K., Handen, B., Johnson, C., Vitiello, B., Bearss, K., Dziura, J, & Scahill, L. (2010). Risperidone and parent-training in pervasive developmental disorders. Reply. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 407.

Hollway, J.A. & Aman M.G. (2011). Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Research in Developmental Disabilities 32, 939-962.

This paper also appeared in American Academy of Child and Adolescent Psychiatry continuing medical education series: Lifelong Learning Module 9: Typical and Atypical Development in Childhood and Adolescence: Protective and Risk Factors, and Relevant Updates for Child and Adolescent Psychiatrists released in October 2012.

Hollway, J.A. & Aman M.G. (2011). Sleep correlates of pervasive developmental disorders: A

review of the literature. Research in Developmental Disabilities, 32, 1299-1421.

Arnold, L. E., Aman, M.C., Hollway, J.A., Hurt, E., Bates, B., Li, X., Farmer, C., Anand, R.,

Thompson, S., Ramadan, Y., Williams, C. (2011). Placebo-controlled pilot of mecamylamine, for treatment of autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 22, 1-8.

Scahill, L., McDougle, C.J., Aman, M.G., Johnson, C.J., Handen, B., Bearrss, K., Dziura, J.,

Butter, E., Swiezy, N.G., Arnold, L.E., Stigler, K.A., Sukhodolsky, D.D., Lecavalier, L., Pozdol, S.L., Nikolov, R., Hollway, J.A., Korzekwa, P., Gavaletz, A., Kohn, A.E., Koenig, K., Grinnon, S., Mulick, J.A., Yu, S., Vitiello, B., Research Units  on Pediatric Psychopharmacology Autism Network. (2013). Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. Journal of the American Academy of Child and Adolescent Psychiatry, 51, 136-146.

Hollway, J.A., Aman, M.G., Butter, E. Correlates and Risk Markers for Sleep Disturbance in

Participants of the Autism Treatment Network. (2013). Journal of Autism and Developmental Disorders, 43, 2830-2843.

Handen, B.L., Johnson, C.R., Butter, E.M., Lecavalier, L., Scahill, L. Aman, M.G., McDougle,

C.J., Arnold, L.E., Swiezy, N.B., Sukhodolsky, D.G., Mulick, J.A., White, S.W., Bearss,

K., Hollway, J.A., Stigler, K.A., Dziura, J., Yu, S., Sacco, K., Vittiello, B. (2013).Use of a direct observational measure in a trial of risperidone and parent training in children with pervasive developmental disorders. Journal of Developmental and Physical Disabilities, 25, 355-371.

Aman, M.G., Smith, T., Arnold, L.E., Corbett-Dick, P., Tumuluru, R., Hollway, J.A., Hyman,

S.L., Mendoza-Burcham, M. A review of atomoxetine effects in young people with developmental disabilities. Aman, M.G., Smith, T., Arnold, L.E., Corbett-Dick, P., Tumuluru, R., Hyman, S.L., Mendoza-Burcham, M. et al. (2014). Research in Developmental Disabilities, 35(6), 1412-1424.

Silverman, L., Hollway, J.A., Smith, T., Aman, M.G., Arnold, L.E., Pan, X., Li, X., Handen,

  1. L. A multisite trial of atomoxetine and parent training in children with autism spectrum disorders: Rationale and design challenges. (2014). Research in Autism Spectrum Disorders 8(7), 899-907.

Handen, B.L, Aman, M.G., Arnold, L.E., Hyman, S.L., Tumuluru, M.V., Lecavalier, L., Corbett-Dick, P., Pan, X., Hollway, J.A., Buchan-Page,K.A., Silverman, L.B., Brown, N.V., Rice,  Jr., R.R., Hellings, J., Mruzek, D.W., McAuliffe-Bellin, S., Hurt, E.A., Ryan, M.M., Levato, L., Smith, T. (Submitted for publication). Atomoxetine, parent training, and their combination in children with autism spectrum and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry.

Aman, M.G., Arnold, L.E., Hollway, J.A. (2015). Assessing change in core autism symptoms:

challenges for pharmacological studies. Journal of Child and Adolescent Psychopharmacology, 25 (4), 282-85.

Aman, M.G., Rettiganti, M., Nagaraja, H.N., Hollway, J.A., McCracken, J., McDougle, C.J., Tierney, E., Scahill, L., Arnold, L.E., Hellings, J., Posey, D.J., Swiezy, N.B., Ghuman, J., Grados, M., Shah, B., Vitiello, B. (In press). Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology.

.Handen, B.L., Aman, M.G., Arnold, L.E. Hyman, S.L., Tumuluru, R.V., Lecavalier, L., Corbett-Dick, P.,

Pan, X.,  Hollway, J.A.,  Buchan-Page, K., Silverman, S.B.,  Brown, N.V.,   Rice, R., Hellings, J., Mruzek, D.W., Sarah McAuliffe-Bellin, S., Hurt, E.A., Ryan, M.M. Levato, L., Smith, T. (In press). Atomoxetine, Parent Training and Their Combination in Children with Autism Spectrum and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry.

Hollway, J.A., Aman, M.G., Mendoza-Burcham, M.I., Silverman, L., Arnold, L.E., Tumuluru,

R., Handen, B.L., Lecavalier, L., Buchan-Page, K., Sayre, P., Smith, T. (2015). Parent Satisfaction with a Multisite Trial of Atomoxetine and Parent Training, for Attention-Deficit Hyperactivity Disorder and Noncompliance in Children with Autism Spectrum Disorder. Manuscript submitted for publication.